Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Stent-Graft
100%
Limb
99%
Ischemia
82%
Percutaneous Transluminal Angioplasty
82%
Deep Vein Thrombosis
77%
Target Lesion Revascularization
65%
Mechanical Thrombectomy
65%
Pulmonary Embolism
64%
Diseases
62%
Incision
61%
Blood Clot Lysis
61%
Revascularization
58%
Knee
56%
Aortic Disease
51%
Aortic Dissection
51%
Aneurysm
49%
Drug-Eluting Stent
46%
Critical Limb Ischemia
46%
Arteriosclerosis Obliterans
44%
Long-Term Outcome
43%
Abdominal Aortic Aneurysm
41%
Venous Thromboembolism
41%
Endovascular Aneurysm Repair
40%
Endovascular Surgery
39%
Randomized Controlled Trial
39%
Apoplexy
36%
Thoracic Aortic Aneurysm
35%
Treatment Option
35%
Restenosis
34%
Thrombus
32%
Paclitaxel
31%
Aortic Arch
30%
Amputation
30%
Leg Ischemia
27%
Ascending Aorta
27%
Surgical Risk
27%
Myocardial Infarction
26%
Inferior Vena Cava
26%
Thromboembolism
26%
Thoracoabdominal Aorta Aneurysm
25%
Arteriovenous Fistula
25%
Artery Disease
25%
Inferior Vena Cava Filter
23%
Post-Thrombotic Syndrome
23%
Arm
23%
All Cause Mortality
22%
Morbidity
21%
Aneurysm Rupture
20%
Aortic Aneurysm Endovascular Graft
20%
Keyphrases
Endovascular Treatment
71%
Mechanical Thrombectomy
65%
Drug-eluting
63%
Catheter-directed Thrombolysis
61%
Balloon Angioplasty
61%
Resorbable Scaffold
61%
Endovascular Repair
61%
Deep Vein Thrombosis
58%
Knee
56%
Zilver PTX
52%
Percutaneous Transluminal Angioplasty
52%
Reintervention
51%
Endovascular
48%
Clinical Outcomes
48%
Critical Limb Ischemia
46%
Drug-eluting Stent
43%
Intermediate-risk Pulmonary Embolism
41%
Thoracic Aortic Disease
41%
Limb-threatening Ischemia
41%
Endovascular Management
41%
Branched Endograft
41%
Major Adverse Events
39%
Descending Thoracic Aortic Aneurysm
37%
Randomized Controlled Trial
37%
Treatment Options
36%
Thoracic Endovascular Aortic Repair (TEVAR)
36%
Endovascular Procedures
36%
Stent
35%
Peripheral Arterial Disease
35%
95% Confidence Interval
34%
Chronic Limb-threatening Ischemia
34%
Aortic Pathology
34%
Randomized Trial
31%
Prospective multicenter
31%
International Registry
30%
Clinical High Risk
29%
Large Bore
29%
Technical Success
29%
Revascularization
29%
Transcarotid Artery Revascularization
28%
Infrapopliteal
28%
Ascending Aorta
27%
1-year Outcome
27%
Infrarenal
27%
Paclitaxel-eluting Stent
25%
Trial Results
24%